238. ビタミンD抵抗性くる病/骨軟化症 Vitamin D-resistant rickets Clinical trials / Disease details


臨床試験数 : 28 薬物数 : 20 - (DrugBank : 9) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 16

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-101332
01/9/201002/11/2010Therapeutic use of Z-521Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial rickets, X-linked hypophosphatemia, vitamin D-resistant rickets) primary hypophosphatemic ricketsIntervention name : Z-521
Dosage And administration of the intervention : 300-3000mg inorganic phosphorus is orally administered in 3 or 4 times per day
Zeria Pharmaceutical Co., Ltd.NULL114BOTH10Phase 3NULL
2NCT01237288
(ClinicalTrials.gov)
September 20107/11/2010Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsTherapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsPrimary Hypophosphatemic RicketsDrug: Z-521Zeria PharmaceuticalNULLCompleted1 Year14 YearsBoth16Phase 3Japan